trending Market Intelligence /marketintelligence/en/news-insights/trending/3eq-3lum9zejii-9xe0qha2 content esgSubNav
In This List

Dr. Reddy's COO to retire; former Teva executive named as replacement

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Dr. Reddy's COO to retire; former Teva executive named as replacement

India's Dr. Reddy's Laboratories Ltd. said its COO, Abhijit Mukherjee, will retire March 31.

Mukherjee, who served at the generic-drug maker for 15 years, will be replaced by Erez Israeli.

Israeli held several senior positions, including vice president of Asia operations and president and CEO of growth markets during his 23 years at Teva Pharmaceutical Industries Ltd.

He is also the former president and CEO of specialty chemicals-maker Enzymotec Ltd., which was acquired by Frutarom Industries Ltd. earlier this year.